SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.05%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$249M
AUM Growth
+$249M
(-25%)
Cap. Flow
-$78.1M
Cap. Flow
% of AUM
-31.36%
Top 10 Holdings %
Top 10 Hldgs %
61.55%
Holding
64
New
7
Increased
31
Reduced
6
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$14.2M |
| 2 |
Disc Medicine
IRON
|
$11.2M |
| 3 |
Sanofi
SNY
|
$9.06M |
| 4 |
Edgewise Therapeutics
EWTX
|
$7.08M |
| 5 |
Maximus
MMS
|
$5.6M |
Top Sells
| 1 |
Icon
ICLR
|
$35.6M |
| 2 |
Zimmer Biomet
ZBH
|
$21.2M |
| 3 |
Labcorp
LH
|
$19.5M |
| 4 |
Teleflex
TFX
|
$14.9M |
| 5 |
Neurocrine Biosciences
NBIX
|
$10.9M |
Sector Composition
| 1 | Healthcare | 83.62% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aligos Therapeutics
ALGS
$73.3M
| $2.42M | 0.93% |
335,937
+155,217
| +86% | +$1.12M |
|
27
Vir Biotechnology
VIR
$686M
| $2.41M | 0.92% |
478,343
+4,736
| +1% | +$23.9K |
|
28
NeuroOne Medical Technologies
NMTC
$38.2M
| $2.39M | 0.91% |
+3,523,663
| New | +$2.39M |
|
29
Senseonics Holdings
SENS
$374M
| $2.31M | 0.88% |
+4,852,298
| New | +$2.31M |
|
30
Travere Therapeutics
TVTX
$1.56B
| $1.81M | 0.69% |
122,210
+1,210
| +1% | +$17.9K |
|
31
Erasca
ERAS
$445M
| $1.74M | 0.66% |
1,369,748
+13,562
| +1% | +$17.2K |
|
32
Astria Therapeutics
ATXS
$349M
| $1.71M | 0.65% |
318,256
+3,151
| +1% | +$16.9K |
|
33
Savara
SVRA
$567M
| $1.66M | 0.63% |
726,851
+7,197
| +1% | +$16.4K |
|
34
Enanta Pharmaceuticals
ENTA
$180M
| $1.35M | 0.52% |
178,774
+1,770
| +1% | +$13.4K |
|
35
TELA Bio
TELA
$70.5M
| $1.23M | 0.47% |
636,300
+6,300
| +1% | +$12.2K |
|
36
Alector
ALEC
$238M
| $1.18M | 0.45% |
845,531
+8,372
| +1% | +$11.7K |
|
37
Context Therapeutics
CNTX
$75.4M
| $879K | 0.34% |
1,341,636
+13,284
| +1% | +$8.7K |
|
38
Ovid Therapeutics
OVID
$91M
| $736K | 0.28% |
2,232,000
| – | – |
|
39
Modular Medical
MODD
$39.9M
| $585K | 0.22% |
785,824
+533,834
| +212% | +$398K |
|
40
Foghorn Therapeutics
FHTX
$286M
| $578K | 0.22% |
122,889
+1,217
| +1% | +$5.72K |
|
41
Aprea Therapeutics
APRE
$9.09M
| $472K | 0.18% |
279,369
+2,766
| +1% | +$4.68K |
|
|
NYXH
42
Nyxoah
NYXH
$234M
| $380K | 0.15% |
50,839
| – | – |
|
43
Avalo Therapeutics
AVTX
$122M
| $360K | 0.14% |
72,173
+715
| +1% | +$3.57K |
|
44
Embecta
EMBC
$847M
| $302K | 0.12% |
31,169
-1,076,444
| -97% | -$10.4M |
|
|
BOLD
45
Boundless Bio
BOLD
$25.1M
| $165K | 0.06% |
163,679
+1,621
| +1% | +$1.64K |
|
46
NextCure
NXTC
$13.5M
| $60.4K | 0.02% |
131,300
+1,300
| +1% | +$598 |
|
47
Terns Pharmaceuticals
TERN
$609M
| $37.7K | 0.01% |
10,100
+100
| +1% | +$373 |
|
48
Humacyte, Inc. Warrant
HUMAW
$32.7M
| $18.7K | 0.01% |
49,998
| – | – |
|
49
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.26M
| $13.6K | 0.01% |
400,000
| – | – |
|
50
Akero Therapeutics
AKRO
$3.74B
| – | – |
-85,000
| Closed | -$3.44M |
|